We are a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these conditions. Our lead product candidate, PBFT02, seeks to treat neurodegenerative conditions, including frontotemporal dementia, by elevating progranulin levels to restore lysosomal function and slow disease progression. Our team's unwavering commitment to excellence is the driving force behind our mission to protect patients and their families against loss in neurodegenerative conditions.
| Website | http://www.passagebio.com/home/default.aspx |
| Revenue | $69.3 million |
| Employees | 43 (36 on RocketReach) |
| Founded | 2017 |
| Address | 2005 Market Street 39th Floor, Philadelphia, Pennsylvania 19103, US |
| Phone | +1 267-866-0311 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+23 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering |
| Keywords | Neurodegenerative Diseases, Gene Therapy, Clinical Stage, Drug Development, Genetic Engineering, Viral Vectors, Rare Diseases, Clinical Trials, Cell Therapy, Precision Medicine, Biotechnology, Regenerative Medicine, Novel Therapies, Pharmaceutical, Medical Research |
| Competitors | Novartis, Vertex Pharmaceuticals, Amicus Therapeutics, bluebird bio, Rocket Pharmaceuticals, REGENXBIO Inc., Sangamo Therapeutics, Inc., Neurogene Inc., GenSight Biologics, Sarepta Therapeutics, Inc. +38 more (view full list) |
Looking for a particular Passage Bio employee's phone or email?
Passage Bio Questions
The Passage Bio annual revenue was $69.3 million in 2026.
Will Chou is the CEO of Passage Bio.
36 people are employed at Passage Bio.
Passage Bio is based in Philadelphia, Pennsylvania.
Top Passage Bio Employees
-
Will Chou
Chief Executive Officer at Passage Bio
Maplewood, NJ, US25+ -
Kathleen Borthwick
Chief Financial Officer at Passage Bio
Hopewell, NJ, US35 -
Susan Browne
Chief Scientific Officer at Passage Bio
Philadelphia, PA, US23 -
Stuart Henderson
Chief Business Officer at Passage Bio
Philadelphia, PA, US24 -
Nayahmka McGriff-Lee
VP, Global Product Strategy at Passage Bio
Philadelphia, PA, US21 -
Robin Derogatis
Vice President Human Resources at Passage Bio
Philadelphia, PA, US25+ -
23
-
Eden Fucci
Sr Vice President, Head of Technical Operations at Passage Bio
Northborough, MA, US22 -
25+
-
25+
Related Companies
